Nephrology

The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

Based on the following article: Sprague SP. Current Medical Research and Opinion 2007;23(12):3167-75

Phosphate Binders Revisited: New Issues Raised

INTRODUCTION The great majority of patients on hemodialysis develop elevated serum phosphorus levels that usually require correction with a phosphate-binding agent. Until recently, calcium-containing phosphate binders as well as...

40th Annual Meeting and Scientific Exhibition of the American Society of Nephrology

Abnormalities in Mineral Metabolism: Improving Quality of Life for Chronic Kidney Disease Patients

San Francisco, California / November 2-5, 2007

San Francisco - Abnormalities in mineral metabolism are common in chronic kidney disease (CKD), increasing in prevalence and severity as patients remain on dialysis. The most important of these mineral abnormalities are elevations in serum...

40th Annual Meeting and Scientific Exhibition of the American Society of Nephrology

Paradigm Shift in the Treatment of Kidney Disease: SMART Findings

San Francisco, California / November 2-5, 2007

San Francisco - Proteinuria is an independent risk factor for progression of both diabetic and non-diabetic kidney disease as it likely contributes to worsening fibrosis and renal impairment. Lowering proteinuria levels in turn reduces the...

40th Annual Meeting and Scientific Exhibition of the American Society of Nephrology

Hyperphosphatemia and the Dialysis Patient: Focus on Reducing Calcification

San Francisco, California / November 2-5, 2007

San Francisco - Elevated phosphorus levels occurring at kidney failure are associated with increased vascular calcification and cardiovascular events. Presently, in dialysis patients, hyperphosphatemia is usually managed with phosphate...

40th Annual Meeting and Scientific Exhibition of the American Society of Nephrology

Paradigm Shift in Proteinuria Reduction for Patients Living with Chronic Kidney Disease

San Francisco, California / October 31-November 5, 2007

San Francisco - Proteinuria is an independent risk factor for progression of both diabetic and non-diabetic kidney disease (KD) and likely contributes to worsening fibrosis and renal impairment. Lowering proteinuria levels in turn reduces...

Transcatheter Cardiovascular Therapeutics 2007

Contrast Agents: Hemodynamics, Electrolytes and Acute Kidney Injury

Washington, DC / October 20-25, 2007

Washington, DC - High-contrast coronary computed tomographic angiography (CTA) is a breakthrough technology for evaluating cardiac patients noninvasively. The ever-expanding volume of CTA procedures ranges in the millions, corresponding...

44th European Renal Association/European Dialysis and Transplant Association Annual Congress

Balancing Needs and Concerns of Dialysis Patients: Simplified Regimens, Enhanced Patient Compliance

Barcelona, Spain / June 21-24, 2007

Barcelona - About one-third of patients with any chronic condition fail to adhere to their medical regimen as prescribed. Non-adherence is a variable behaviour and is rooted in a patient’s pre-existing set of beliefs about how important a...

National Kidney Foundation Spring 2007 Clinical Meeting

Optimizing Serum Phosphorus Control: Towards Enhanced Compliance

Orlando, Florida / April 10-14, 2007

Orlando - Chronic kidney disease demands optimal management in order to offset a generally poor prognosis. Among the most important elements that require consistent regulation is serum phosphorus. Phosphate binders have long been used to...

22nd European Association of Urology Annual Congress

Targeted Therapy in Advanced Renal Cell Carcinoma: Extending Patients’ Lives

Berlin, Germany / March 21-24, 2007

Berlin - A better understanding of the pathological processes implicated in renal cell carcinoma (RCC) has enabled the development of targeted therapies. Tyrosine kinase inhibitors (TKIs) represent a particularly promising class of...

Nephrogenic Systemic Fibrosis/Nephrogenic Fibrosing Dermopathy: Focus on Gadolinium-based Contrast Media

Philadelphia, Pennsylvania / November 18, 2006

EDITORIAL OVERVIEW: Dr. James A. Tumlin Director of Clinical Research Southeast Renal Associates Associate Professor of Medicine University of North Carolina at Charlotte Charlotte, North Carolina PANEL Dr. Stanley Goldfarb University of...

PAGE 4 OF 6   1 2 3 4 5 6